The primary vision of the UCD Academic Centre in Translational Oncology (ACTO) is to (a) acknowledge and foster the exceptional cancer initiatives already in place, with a particular focus on gaining international recognition within academic and industrial sectors, and (b) to unify the basic, translational and clinical cancer research communities across all UCD affiliated hospitals, Dublin East Hospitals, Institutes and Schools.
The ACTO translational research agenda envisages collaboration with other centres of cancer research activity (physical and virtual) to improve patient outcomes.
Translational Oncology is the crucial bridge that enables application of scientific discoveries into clinical practice with the intention of improving clinical outcomes of cancer treatment. This can only be achieved by establishing a critical mass of clinicians and researchers, driven by a similar agenda. The recent creation of the Dublin East network of hospitals, provides a catchment population in excess of one million and includes two of the eight designated centres in Ireland (Mater Misericordiae University Hospital and St Vincent’s University Hospital) that together currently treat the largest numbers of patients affected by all the major cancers (Breast, Prostate, Colorectal, Lung, Pancreas) within the country. This critical mass provides opportunities for enhanced basic research collaboration but also crucially will greatly enhance interactions with the pharmaceutical and medical device industries.